Cleveland Diagnostics

Develops non-invasive diagnostic tests for early detection of cancers, including prostate cancer.

What is Cleveland Diagnostics?

Cleveland Diagnostics is a clinical-stage biotechnology company specializing in developing advanced diagnostic tests for early cancer detection. Founded in 2013, the company is best known for its IsoPSA test, which offers a more accurate assessment of prostate cancer risk compared to traditional PSA tests. By utilizing innovative technology, Cleveland Diagnostics aims to improve the way cancer is diagnosed, ultimately reducing unnecessary procedures and enhancing patient outcomes.

Key Features:

  • IsoPSA Test: This blood test distinguishes between benign and malignant prostate conditions with high sensitivity and specificity, significantly lowering the rate of unnecessary biopsies. The IsoPSA test has shown to reduce the need for biopsies by up to 55%, providing clearer insights into whether aggressive cancer may be present​FierceBiotech

  • Cleveland Diagnostics

  • .

  • Solvent Interaction Analysis (SIA): The company’s proprietary technology analyzes structural changes in protein biomarkers, allowing for better detection of cancerous changes at a molecular level. This approach is pivotal in creating affordable and reliable diagnostic tests​Pubs - Bio-IT World

  • Cleveland Diagnostics

  • .

  • Expanding Portfolio: Cleveland Diagnostics plans to broaden its range of diagnostic tests beyond prostate cancer, targeting other cancers and conditions, thus addressing a wider spectrum of patient needs​FierceBiotech

  • Pubs - Bio-IT World

  • .

Summary

Cleveland Diagnostics is a leader in cancer diagnostics, providing innovative solutions like the IsoPSA test for early prostate cancer detection. With its commitment to research and advanced technology, the company enhances the diagnostic landscape, focusing on improving patient outcomes while addressing the critical need for accurate cancer screening methods.

Similar Listings

Ancora.ai

AI platform matching patients with suitable clinical trials.

Oncology
Visit Website

Arterys

AI-powered medical imaging platform for improved diagnostics.

Oncology
Visit Website

BenevolentAI

Biotechnology company using AI for drug discovery and development to create treatments for diseases.

Oncology
Visit Website